| Field | Specification |
|---|---|
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
LipoJet™ Transfection Buffer was formulated for use with LipoJet™ siRNA & DNA Transfection Reagent, supporting optimal transfection efficiency and maximum knockdown of gene expression. The buffer is used to dilute siRNA/DNA and LipoJet™ Transfection Reagent so that the most efficient transfection complex can form. LipoJet™ Transfection Buffer(5x), 8.0 mL, is supplied as a 5x concentrated stock solution that yields 40 mL of working solution.
Specifications
| Transfection Type | Buffer |
|---|---|
| Pre-Optimized | No — General-Purpose Formulation |
| Storage | Store at RT. If stored properly, the product is stable for 12 months or longer. |
Kit Contents
- LipoJet™ Transfection Buffer, 8.0 mL/vial, to make 40 mL of working solution (1x ), sufficient for 1000 transfections in 24-well plate
Applications
This transfection buffer is used to prepare transfection complexes with the matching SignaGen transfection reagent, for both DNA and siRNA delivery. Use it to dilute the nucleic acid and the reagent as described in the protocol.
Safety & Handling
Can't Find What You're Looking For? We can help you source the best match or customize a transfection solution for your study. Options may include pre-optimized formulations for a cell line not listed here, matching transfection buffer supplied with the reagent, DNA, siRNA or in vivo formats within the same reagent family, and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Ou J, Ball J, Luan Y, et al.. iPSCs from a Hibernator Provide a Platform for Studying Cold Adaptation and Its Potential Medical Applications. Cell (2018) 173(4), 851-863.e16.. 10.1016/j.cell.2018.03.010
Zhou H, Wang H, Ni M, et al.. Glycogen synthase kinase 3β promotes liver innate immune activation by restraining AMP-activated protein kinase activation. J Hepatol (2018) 69(1), 99-109.. 10.1016/j.jhep.2018.01.036
Lu H, Ballout F, Chen L, et al.. Targeting APE1-Redox Function Reverses SOX9-mediated Chemoresistance in Esophageal Adenocarcinoma. Gastroenterology (2026). 10.1053/j.gastro.2025.12.019
Cao L, Zhu S, Lu H, et al.. Helicobacter pylori-induced RASAL2 Through Activation of Nuclear Factor-κB Promotes Gastric Tumorigenesis via β-catenin Signaling Axis. Gastroenterology (2022) 162(6), 1716-1731.e17.. 10.1053/j.gastro.2022.01.046
